Hyperhomocysteinemia accompany with metabolic syndrome increase the risk of left ventricular hypertrophy in rural Chinese
- PMID: 32013876
- PMCID: PMC6998833
- DOI: 10.1186/s12872-020-01350-2
Hyperhomocysteinemia accompany with metabolic syndrome increase the risk of left ventricular hypertrophy in rural Chinese
Abstract
Background: To investigate the influence of hyperhomocysteinemia (HHcy) and metabolic syndrome (MetS) on left ventricular hypertrophy (LVH) in residents in rural Northeast China.
Methods: We performed a cross-sectional baseline data analysis of 6837 subjects (mean age: 54 ± 10 years) recruited from a rural area of China. Anthropometric indicators were measured according to standard methods. MetS was defined by the modified ATP III criteria. HHcy was defined according to the WHO standard: an Hcy level > 15 μmol/L representing HHcy. Four groups were defined: non-HHcy & non-MetS, HHcy & non-MetS, MetS & non-HHcy and HHcy & MetS.
Results: The left ventricular mass index for height2.7 (LVMH2.7) in both sexes was significantly higher in the HHcy & MetS group than in the non-HHcy & non-MetS group (females: 51.23 ± 16.34 vs. 40.09 ± 10.55 g-2.7, P < 0.001; males: 48.67 ± 12.24 g-2.7 vs. 42.42 ± 11.38 g-2.7, P < 0.001). A similar result was observed in those groups when using the left ventricular mass index (LVMI) for body surface area to define LVH (females: 103.58 ± 31.92 g- 2 vs. 86.63 ± 20.47 g- 2, P < 0.001; males: 106.10 ± 24.69 g- 2 vs. 98.16 ± 23.29 g- 2, P < 0.001). The results of multiple regression analysis indicated that the HHcy & MetS group had a higher risk of LVH than the other three groups (OR: 1.628 for LVMI, P < 0.001, OR: 2.433 for LVMH2.7, P < 0.001). Moreover, subjects in the HHcy & non-MetS group [OR (95% CI): 1.297 (1.058, 1.591) for LVMI, P < 0.05; OR (95% CI): 1.248 (1.044, 1.492) for LVMH2.7, P < 0.05] also had a statistically greater risk of LVH than subjects in the non-HHcy & non-MetS group. The HHcy & non-MetS group was also found to be significantly and independently associated with LVH.
Conclusion: Hyperhomocysteinemia has an independent effect on LVH. The combined effect of MetS and hyperhomocysteinemia might increase the strength of the abovementioned effects.
Keywords: Hyperhomocysteinemia; Left ventricular hypertrophy; Metabolic syndrome; Predictor; Rural.
Conflict of interest statement
The authors declare that they have no competing interests.
Figures
Similar articles
-
Combination of hyperuricemia and metabolic syndrome is an independent and powerful predictor for left ventricular hypertrophy in rural Chinese.Ann Endocrinol (Paris). 2015 Jul;76(3):264-71. doi: 10.1016/j.ando.2015.01.002. Epub 2015 Jun 30. Ann Endocrinol (Paris). 2015. PMID: 26141680
-
Hyperhomocysteinemia independently associated with the risk of hypertension: a cross-sectional study from rural China.J Hum Hypertens. 2016 Aug;30(8):508-12. doi: 10.1038/jhh.2015.75. Epub 2015 Jul 9. J Hum Hypertens. 2016. PMID: 26155996
-
Gender-specific contribution of cardiometabolic index and lipid accumulation product to left ventricular geometry change in general population of rural China.BMC Cardiovasc Disord. 2018 Apr 10;18(1):62. doi: 10.1186/s12872-018-0798-0. BMC Cardiovasc Disord. 2018. PMID: 29631555 Free PMC article.
-
Homocysteine, hyperhomocysteinemia, and H-type hypertension.Eur J Prev Cardiol. 2024 Jul 23;31(9):1092-1103. doi: 10.1093/eurjpc/zwae022. Eur J Prev Cardiol. 2024. PMID: 38236144 Review.
-
The Interaction between Arachidonic Acid Metabolism and Homocysteine.Endocr Metab Immune Disord Drug Targets. 2021;21(7):1232-1241. doi: 10.2174/1871530320999200904130504. Endocr Metab Immune Disord Drug Targets. 2021. PMID: 32888285 Review.
Cited by
-
The Roles of Aerobic Exercise and Folate Supplementation in Hyperhomocysteinemia-Accelerated Atherosclerosis.Acta Cardiol Sin. 2023 Mar;39(2):309-318. doi: 10.6515/ACS.202303_39(2).20221027A. Acta Cardiol Sin. 2023. PMID: 36911543 Free PMC article.
-
Progress in diagnosis and treatment of hypertension combined with left ventricular hypertrophy.Ann Med. 2024 Dec;56(1):2405080. doi: 10.1080/07853890.2024.2405080. Epub 2024 Sep 20. Ann Med. 2024. PMID: 39301864 Free PMC article. Review.
-
Vitamin B12, folate, and homocysteine in metabolic syndrome: a systematic review and meta-analysis.Front Endocrinol (Lausanne). 2023 Sep 13;14:1221259. doi: 10.3389/fendo.2023.1221259. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37772082 Free PMC article.
-
Hypertension-Mediated Organ Damage Correlates With Serum Homocysteine Level in Community-Dwelling Elderly Chinese: The North Shanghai Study.Front Cardiovasc Med. 2021 May 10;8:662741. doi: 10.3389/fcvm.2021.662741. eCollection 2021. Front Cardiovasc Med. 2021. PMID: 34041284 Free PMC article.
-
Homocysteine and the Risk of Cardiovascular Events and All-Cause Death in Elderly Population: A Community-Based Prospective Cohort Study.Ther Clin Risk Manag. 2020 May 22;16:471-481. doi: 10.2147/TCRM.S239496. eCollection 2020. Ther Clin Risk Manag. 2020. PMID: 32547044 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical